Last Chance: Get 30 Days of MarketBeat All Access for FREE, then just $399 $199 for the year.
Start free trial
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
EXTENDED - TODAY ONLY: MarketBeat All Access For Just $399 $199 (save 50%)
Special Offer: Just $199
×
S&P 500   3,957.63 (-0.16%)
DOW   33,852.53 (+0.01%)
QQQ   280.31 (-0.85%)
AAPL   141.15 (-2.13%)
MSFT   240.29 (-0.61%)
META   109.29 (+0.47%)
GOOGL   95.15 (-0.94%)
AMZN   92.30 (-1.76%)
TSLA   180.83 (-1.14%)
NVDA   156.00 (-1.43%)
NIO   10.52 (+3.95%)
BABA   79.73 (+5.07%)
AMD   73.20 (+0.01%)
T   19.00 (+0.96%)
MU   53.71 (-3.66%)
CGC   3.43 (+0.88%)
F   13.75 (+0.15%)
GE   85.55 (+0.09%)
DIS   94.69 (-1.05%)
AMC   7.45 (+1.64%)
PYPL   77.66 (-2.84%)
PFE   49.42 (-0.30%)
NFLX   280.79 (-0.14%)
S&P 500   3,957.63 (-0.16%)
DOW   33,852.53 (+0.01%)
QQQ   280.31 (-0.85%)
AAPL   141.15 (-2.13%)
MSFT   240.29 (-0.61%)
META   109.29 (+0.47%)
GOOGL   95.15 (-0.94%)
AMZN   92.30 (-1.76%)
TSLA   180.83 (-1.14%)
NVDA   156.00 (-1.43%)
NIO   10.52 (+3.95%)
BABA   79.73 (+5.07%)
AMD   73.20 (+0.01%)
T   19.00 (+0.96%)
MU   53.71 (-3.66%)
CGC   3.43 (+0.88%)
F   13.75 (+0.15%)
GE   85.55 (+0.09%)
DIS   94.69 (-1.05%)
AMC   7.45 (+1.64%)
PYPL   77.66 (-2.84%)
PFE   49.42 (-0.30%)
NFLX   280.79 (-0.14%)
S&P 500   3,957.63 (-0.16%)
DOW   33,852.53 (+0.01%)
QQQ   280.31 (-0.85%)
AAPL   141.15 (-2.13%)
MSFT   240.29 (-0.61%)
META   109.29 (+0.47%)
GOOGL   95.15 (-0.94%)
AMZN   92.30 (-1.76%)
TSLA   180.83 (-1.14%)
NVDA   156.00 (-1.43%)
NIO   10.52 (+3.95%)
BABA   79.73 (+5.07%)
AMD   73.20 (+0.01%)
T   19.00 (+0.96%)
MU   53.71 (-3.66%)
CGC   3.43 (+0.88%)
F   13.75 (+0.15%)
GE   85.55 (+0.09%)
DIS   94.69 (-1.05%)
AMC   7.45 (+1.64%)
PYPL   77.66 (-2.84%)
PFE   49.42 (-0.30%)
NFLX   280.79 (-0.14%)
S&P 500   3,957.63 (-0.16%)
DOW   33,852.53 (+0.01%)
QQQ   280.31 (-0.85%)
AAPL   141.15 (-2.13%)
MSFT   240.29 (-0.61%)
META   109.29 (+0.47%)
GOOGL   95.15 (-0.94%)
AMZN   92.30 (-1.76%)
TSLA   180.83 (-1.14%)
NVDA   156.00 (-1.43%)
NIO   10.52 (+3.95%)
BABA   79.73 (+5.07%)
AMD   73.20 (+0.01%)
T   19.00 (+0.96%)
MU   53.71 (-3.66%)
CGC   3.43 (+0.88%)
F   13.75 (+0.15%)
GE   85.55 (+0.09%)
DIS   94.69 (-1.05%)
AMC   7.45 (+1.64%)
PYPL   77.66 (-2.84%)
PFE   49.42 (-0.30%)
NFLX   280.79 (-0.14%)
NYSE:CO

Global Cord Blood - CO Stock Forecast, Price & News

$2.99
0.00 (0.00%)
(As of 11/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.99
▼
$2.99
50-Day Range
$2.22
▼
$2.99
52-Week Range
$2.03
▼
$5.50
Volume
N/A
Average Volume
N/A
Market Capitalization
$363.14 million
P/E Ratio
4.67
Dividend Yield
N/A
Price Target
N/A
CO stock logo

About Global Cord Blood (NYSE:CO) Stock

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Receive CO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter.

CO Stock News Headlines

November 28, 2022 | americanbankingnews.com
StockNews.com Begins Coverage on Global Cord Blood (NYSE:CO)
November 26, 2022 | marketwatch.com
What is a Revenue Expectation of Cord Blood Banking Services Market to 2028?
November 22, 2022 | marketwatch.com
Cord Blood Banking Market is expected to rise with an impressive CAGR and generate the highest revenue by 2028
November 21, 2022 | americanbankingnews.com
Comparing Global Cord Blood (NYSE:CO) & Lisata Therapeutics (NASDAQ:LSTA)
November 20, 2022 | marketwatch.com
Umbilical Cord Blood Banking Market 2022 : Company Profile Analysis, Industry Segmentation, Opportunity Assessment and Forecast by 2028
November 18, 2022 | marketwatch.com
Cord Blood Banking Services Market Size 2023 with New Report by Prominent Players & Peak Selling Price till 2027
November 16, 2022 | marketwatch.com
Global Stem Cell Umbilical Cord Blood Market Size 2022 Production by Market Dynamics, Trends, Applications, Consumption and Demand Forecast to 2028
November 15, 2022 | marketwatch.com
Cord Blood Banking Services Market 2022 : Trends, Industry Size, Share, Emerging Trends, Top Leading Players and Forecast 2028
November 9, 2022 | marketwatch.com
Cord Blood Banking Services Market Global Outlook with Top Key Players & Forecast up to 2028
November 9, 2022 | marketwatch.com
Blood Thaw Equipment Market 2022 Key Product Segments, Application Analysis, and Industry Growth Forecast by 2028
November 9, 2022 | marketwatch.com
Cord Blood Stem Cells Market 2022 - Product Type, Ongoing Trends, Competitive Insights and Worldwide Forecast to 2028
November 7, 2022 | finanznachrichten.de
Stem Cell Banking Market is expected to generate a revenue of USD 10.31 Billion by 2028, Globally, at 20.17% CAGR: Verified Market Research
November 4, 2022 | benzinga.com
Stem Cell Banking Market Global Report 2022-2027, Spurred by Rising Prevalence of Chronic Diseases
October 22, 2022 | marketwatch.com
Cord Blood Banking Service Market Size From 2022 To 2028 And Unlimited Opportunities for New Companies
October 17, 2022 | finance.yahoo.com
Global Cord Blood Banking Global Market Report 2022: Featuring Americord Registry, Cordlife Group, Lifecell International & More
October 14, 2022 | marketwatch.com
Cord Blood Banking Services Market Trends, Business Overview, Industry Growth, and Forecast 2022 To 2029 | 132 Pages Report
October 11, 2022 | marketwatch.com
Umbilical Cord Blood Banking Market 2022 | Assess the Market Competitive Situation, Upcoming Trends, Major Manufacturers and Forecast to 2028
October 10, 2022 | marketwatch.com
Global Cord Blood Banking Market 2022 Offers a Detailed Study on Development and Market Trends Adopted by Competitors and Forecasts to 2027
October 7, 2022 | finance.yahoo.com
Global Cord Blood Banking Market - Competition Forecast and Opportunities, 2027
October 4, 2022 | marketwatch.com
Cord Blood Banking Services Market Share 2022, Growth, Demand, Size, Analysis and Forecast to 2027
September 29, 2022 | marketwatch.com
Umbilical Cord Blood Banking Market 2022 Key Product Segments, Application Analysis, and Industry Growth Forecast by 2027
September 27, 2022 | nz.finance.yahoo.com
Research 2022, Biobanking Market Size Is Projected to Reach USD 49.46 Billion in 2026 while exhibiting a CAGR of 8.9%
September 26, 2022 | finance.yahoo.com
Global Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman Islands
September 26, 2022 | ca.finance.yahoo.com
Mesenchymal stem cells market is projected to grow at a CAGR of 13.82% by 2032: Visiongain Research Inc
September 23, 2022 | finance.yahoo.com
The Grand Court of the Cayman Islands Granted Blue Ocean’s Application to Appoint Joint Provisional Liquidators for Global Cord Blood Corporation
See More Headlines
Receive CO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter.

CO Company Calendar

Last Earnings
6/26/2018
Today
11/29/2022
Fiscal Year End
3/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSE:CO
CUSIP
N/A
CIK
1467808
Web
www.globalcordbloodcorp.com
Phone
(523) 605-8180
Fax
852-3605-8181
Employees
1,202
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
$0.64
Trailing P/E Ratio
4.67
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$79.04 million
Net Margins
40.29%
Pretax Margin
50.50%
Return on Equity
10.63%
Return on Assets
6.02%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.73
Quick Ratio
10.66

Sales & Book Value

Annual Sales
$196.12 million
Price / Sales
1.85
Cash Flow
$0.71 per share
Price / Cash Flow
4.19
Book Value
$6.34 per share
Price / Book
0.47

Miscellaneous

Outstanding Shares
121,550,000
Free Float
N/A
Market Cap
$363.14 million
Optionable
Optionable
Beta
-0.04

Key Executives

  • Ms. Ting Zheng (Age 50)
    CEO & CEO of Beijing Division
    Comp: $516.68k
  • Mr. Bing Chuen Chen (Age 46)
    Chief Financial Officer
    Comp: $516.68k
  • Ms. Xin Xu (Age 68)
    Chief Technology Officer
    Comp: $122.78k
  • Ms. Rui Arashiyama (Age 63)
    Chief Exec. Officer of Guangdong & Zhejiang Divisions
    Comp: $257.5k
  • Ms. Cathy Bai
    VP of Corp. Fin.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













CO Stock - Frequently Asked Questions

How have CO shares performed in 2022?

Global Cord Blood's stock was trading at $4.19 at the beginning of 2022. Since then, CO shares have decreased by 28.7% and is now trading at $2.9876.
View the best growth stocks for 2022 here.

How were Global Cord Blood's earnings last quarter?

Global Cord Blood Co. (NYSE:CO) released its quarterly earnings results on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.13 by $0.09. The medical research company earned $37.14 million during the quarter. Global Cord Blood had a net margin of 40.29% and a trailing twelve-month return on equity of 10.63%.

What other stocks do shareholders of Global Cord Blood own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Vertex Pharmaceuticals (VRTX), Enphase Energy (ENPH), Galectin Therapeutics (GALT), Intel (INTC) and Marvell Technology (MRVL).

What is Global Cord Blood's stock symbol?

Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."

Who are Global Cord Blood's major shareholders?

Global Cord Blood's stock is owned by a variety of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (1.93%), BlueCrest Capital Management Ltd (0.62%), Benjamin F. Edwards & Company Inc. (0.05%), Marshall Wace LLP (0.01%), Simplex Trading LLC (0.00%) and Group One Trading L.P. (0.00%).
View institutional ownership trends.

How do I buy shares of Global Cord Blood?

Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global Cord Blood's stock price today?

One share of CO stock can currently be purchased for approximately $2.99.

How much money does Global Cord Blood make?

Global Cord Blood (NYSE:CO) has a market capitalization of $363.14 million and generates $196.12 million in revenue each year. The medical research company earns $79.04 million in net income (profit) each year or $0.64 on an earnings per share basis.

How many employees does Global Cord Blood have?

The company employs 1,202 workers across the globe.

How can I contact Global Cord Blood?

Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The official website for the company is www.globalcordbloodcorp.com. The medical research company can be reached via phone at (523) 605-8180, via email at ir@globalcordbloodcorp.com, or via fax at 852-3605-8181.

This page (NYSE:CO) was last updated on 11/29/2022 by MarketBeat.com Staff